Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New LXR modulators in Pharmacia development pipeline

Aug. 26, 2003

Novel MCH receptor modulators under study at Neurogen

Aug. 26, 2003

Selective agonists of thyroid hormone receptors may have utility in obesity

Aug. 26, 2003

Axovan scientists present novel antiobesity NPY Y5 antagonists

Aug. 25, 2003

Merck & Co. discontinues development of first Karo Bio collaboration compound

Aug. 25, 2003

Novel PPARalpha agonists under study at Sigma-Tau

Aug. 22, 2003

Advantages for insulin/metformin vs. triple oral therapy in type 2 diabetes

Aug. 22, 2003

Merck patent covers novel insulin receptor kinase activators

Aug. 21, 2003

Raloxifene reduces likelihood of developing osteoporosis and demonstrates uterine safety

Aug. 21, 2003

Scientists at Sumitomo identify novel PPARdelta agonists

Aug. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...